STORK A.R.T. Clinic, Thailand

Si, meaning offspring. Dao, meaning path. Thus, Sidao, the path to seeking children, where every prayer is answered. Si, meaning inheritance. Dao, meaning the law of conception. Thus, Sidao, imparting the way of conception, healing the world with medical skill. Sidao Eugenics, originating from the Western legend of Stork delivering babies, brings together renowned medical experts from China and abroad, meticulously studying the art of conception.

Sidao Eugenics has long focused on reproductive health, pregnancy preparation, fertility preservation, and 1-3 generation IVF, committed to addressing every fertility-related need of modern people. It also operates green channel services for joint diagnosis and treatment with multiple well-known hospitals in China, achieving coordinated domestic and international care, shortening overseas stay duration, and providing comprehensive, integrated eugenic pregnancy assistance solutions for more families.

Under the Sidao company, Sidao (Thailand) Reproductive Specialty Hospital is located in central Bangkok, Thailand. Certified by the Royal Thai College of Obstetricians and Gynaecologists, its core expert team, led by Dr. Charnin, a leading figure in Thailand's reproductive medicine field, provides comprehensive assisted reproduction solutions, genetic disease screening and diagnosis, and other medical services to clients. The hospital independently operates a genetic testing center and is one of the few reproductive institutions in Thailand with independently developed PGT technology and a laboratory system meeting European and American standards, dedicated to helping millions of families have a healthy baby.

1998 Founder began working in the assisted reproduction industry in 1998

2002 Founder returned to China in 2002 and served as Sales Director for the Greater China region in the obstetrics, gynecology, and assisted reproduction fields at Organon Pharmaceuticals. He maintained close cooperation with domestic and international experts in obstetrics, gynecology, and assisted reproduction, building academic and technical platforms for many domestic prenatal diagnosis centers and reproductive centers to connect with the international community

2009 Founded Hezhuo Biotech, focusing on prenatal screening, prenatal diagnosis, and eugenics. It independently developed single-cell isolation and detection technology and is a high-tech enterprise based on genomics and cytomics, developing scientific research and clinical applications, providing full product chain services including upstream, midstream, and downstream single-cell detection for many top-tier hospitals in China

2014 Founded Sidao. Sidao (Thailand) Reproductive Specialty Hospital is one of the few medical institutions in Thailand that operates in accordance with American laboratory system management standards, has obtained certification from the Royal Thai College of Obstetricians and Gynaecologists, and holds a license

2015 year 11 month Sidao's first third-generation IVF baby born healthy after whole-genome screening

2016 As the only reproductive center in Thailand simultaneously equipped with Karyomapping (karyotype positioning technology) and preimplantation HLA matching technology, these two technologies were applied to numerous families suffering from chromosomal diseases. In the same year, Sidao was recommended as a reproductive center by the Thai Ministry of Public Health (MOPH) and designated as a medical tourism promotion unit by the Thai Ministry of Health, maintaining long-term exchanges of experience and technology with domestic and international experts

2018 Sidao's 1000th baby was born healthy

2019 Authoritative domestic media reported that the world's first newborn successfully delivered with imprinting gene disease Schaaf-Yang syndrome blocked through preimplantation genetic testing technology. As an industry leader, Sidao provided comprehensive solutions for many families troubled by genetic diseases in the application of this technology

2022 year 8 month The world's first PGT-P male infant based on family genetic information was born in China. As an industry leader, Sidao plans to provide solutions for families with polygenic genetic diseases in the application of this technology

2023 Focused on establishing a database for female consumer platforms on fertility preservation, transitioning from pure medical services to medical consumption

1998 Founder began working in the assisted reproduction industry in 1998

2002 Founder returned to China in 2002 and served as Sales Director for the Greater China region in the obstetrics, gynecology, and assisted reproduction fields at Organon Pharmaceuticals. He maintained close cooperation with domestic and international experts in obstetrics, gynecology, and assisted reproduction, building academic and technical platforms for many domestic prenatal diagnosis centers and reproductive centers to connect with the international community

2009 Founded Hezhuo Biotech, focusing on prenatal screening, prenatal diagnosis, and eugenics. It independently developed single-cell isolation and detection technology and is a high-tech enterprise based on genomics and cytomics, developing scientific research and clinical applications, providing full product chain services including upstream, midstream, and downstream single-cell detection for many top-tier hospitals in China

2014 Founded Sidao. Sidao (Thailand) Reproductive Specialty Hospital is one of the few medical institutions in Thailand that operates in accordance with American laboratory system management standards, has obtained certification from the Royal Thai College of Obstetricians and Gynaecologists, and holds a license

2015 year 11 month Sidao's first third-generation IVF baby born healthy after whole-genome screening

2016 As the only reproductive center in Thailand simultaneously equipped with Karyomapping (karyotype positioning technology) and preimplantation HLA matching technology, these two technologies were applied to numerous families suffering from chromosomal diseases. In the same year, Sidao was recommended as a reproductive center by the Thai Ministry of Public Health (MOPH) and designated as a medical tourism promotion unit by the Thai Ministry of Health, maintaining long-term exchanges of experience and technology with domestic and international experts

2018 Sidao's 1000th baby was born healthy

2019 Authoritative domestic media reported that the world's first newborn successfully delivered with imprinting gene disease Schaaf-Yang syndrome blocked through preimplantation genetic testing technology. As an industry leader, Sidao provided comprehensive solutions for many families troubled by genetic diseases in the application of this technology

2022 year 8 month The world's first PGT-P male infant based on family genetic information was born in China. As an industry leader, Sidao plans to provide solutions for families with polygenic genetic diseases in the application of this technology

2023 Focused on establishing a database for female consumer platforms on fertility preservation, transitioning from pure medical services to medical consumption